Ahead of Cigna (CI) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

27.10.25 14:15 Uhr

Werte in diesem Artikel
Aktien

259,15 EUR -2,45 EUR -0,94%

Indizes

6.861,0 PKT 69,3 PKT 1,02%

Wall Street analysts forecast that Cigna (CI) will report quarterly earnings of $7.70 per share in its upcoming release, pointing to a year-over-year increase of 2.5%. It is anticipated that revenues will amount to $67.16 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.Given this perspective, it's time to examine the average forecasts of specific Cigna metrics that are routinely monitored and predicted by Wall Street analysts.The consensus estimate for 'Revenues- Pharmacy' stands at $53.14 billion. The estimate points to a change of +10.1% from the year-ago quarter.The combined assessment of analysts suggests that 'Revenues- Premiums' will likely reach $9.03 billion. The estimate suggests a change of -21.1% year over year.Based on the collective assessment of analysts, 'Revenues- Net investment income' should arrive at $245.97 million. The estimate indicates a change of +189.4% from the prior-year quarter.It is projected by analysts that the 'Revenues- Evernorth Health Services' will reach $57.17 billion. The estimate indicates a change of +9% from the prior-year quarter.According to the collective judgment of analysts, 'Revenues- Cigna Healthcare' should come in at $10.95 billion. The estimate indicates a change of -17.9% from the prior-year quarter.Analysts predict that the 'Revenues- Fees and Other' will reach $4.29 billion. The estimate points to a change of +10.3% from the year-ago quarter.Analysts forecast 'Services (Fees)- Evernorth Health Services' to reach $3.69 billion. The estimate indicates a year-over-year change of +11.3%.The average prediction of analysts places 'Services (Fees)- Cigna Healthcare' at $1.89 billion. The estimate points to a change of +13.4% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Premiums- Cigna Healthcare- U.S. Healthcare- Individual and Family Plans' of $877.94 million. The estimate points to a change of -12.3% from the year-ago quarter.Analysts' assessment points toward 'Medical Care Ratio - Cigna Healthcare' reaching 84.2%. Compared to the present estimate, the company reported 82.8% in the same quarter last year.The consensus among analysts is that 'Healthcare Medical Customers - Administrative services only - U.S. Healthcare' will reach 13.78 million. The estimate is in contrast to the year-ago figure of 13.57 million.Analysts expect 'Medical Customers - Total' to come in at 18.06 million. The estimate is in contrast to the year-ago figure of 19.05 million. View all Key Company Metrics for Cigna here>>> Over the past month, Cigna shares have recorded returns of +5.5% versus the Zacks S&P 500 composite's +2.5% change. Based on its Zacks Rank #3 (Hold), CI will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cigna Group (CI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: The Cigna Group Registered und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf The Cigna Group Registered

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf The Cigna Group Registered

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu The Cigna Group Registered Shs

Wer­bung

Analysen zu The Cigna Group Registered Shs

DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
14.12.2017Express Scripts BuyMaxim Group
04.12.2017Express Scripts BuyDeutsche Bank AG
DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
19.09.2017Express Scripts Sector PerformRBC Capital Markets
21.07.2017Express Scripts HoldNeedham & Company, LLC
26.04.2017Express Scripts HoldEdward Jones
DatumRatingAnalyst
22.02.2016Express Scripts SellDeutsche Bank AG
13.01.2009CIGNA sellCitigroup Corp.
07.11.2007CIGNA underweightLehman Brothers Inc.
02.11.2006Update CIGNA Corp.: UnderweightLehman Brothers

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen